Accent Capital Management’s NeuroMetrix, Inc. Common Stock NURO Stock Holding History

Accent Capital Management’s Portfolio NURO Stock Details NURO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-300	Closed	-$1.33K	–	427
2025 Q1	$1.33K	Hold	300	–	–	﹤0.01%	314
2024 Q4	$1.19K	Hold	300	–	–	﹤0.01%	184
2024 Q3	$1.19K	Sell	300 -325	-52%	-$1.19K	﹤0.01%	203
2024 Q2	$2.31K	Hold	625	–	–	﹤0.01%	170
2024 Q1	$2.66K	Hold	625	–	–	﹤0.01%	156
2023 Q4	$2.25K	Buy	+625	New	+$2.63K	﹤0.01%	204

Accent Capital Management's NURO Position: Q2 2025 in Review

Accent Capital Management sold out of NeuroMetrix, Inc. Common Stock (NURO) in Q2 2025, closing a stake of 300 shares — an estimated $1.33K sold.

Accent Capital Management first reported a position in NURO in Q4 2023 and held it in 6 quarters. The position peaked at $2.66K in Q1 2024. 0 funds tracked by Wall St. Rank hold NURO as of Q2 2025.

Accent Capital Management reported no remaining NeuroMetrix, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
Accent Capital Management sold 300 NeuroMetrix, Inc. Common Stock shares in Q2 2025, an estimated $1.33K.
Accent Capital Management first reported a position in NeuroMetrix, Inc. Common Stock in Q4 2023 and held it in 6 quarters.
Accent Capital Management's NeuroMetrix, Inc. Common Stock position peaked at $2.66K in Q1 2024.
0 funds tracked by Wall St. Rank held NeuroMetrix, Inc. Common Stock as of Q2 2025.

Based on Accent Capital Management's 13F filing for Q2 2025, filed 7 Aug 2025.